Market Research Report Analysis

  The global urinalysis market size was estimated at USD 4.37 billion in 2024 and is projected to reach USD 6.85 billion by 2030, growing at a CAGR of 7.83% from 2025 to 2030. Market growth is being driven by the increasing prevalence of health conditions such as Urinary Tract Infections (UTIs), diabetes, and kidney diseases, all of which require frequent and accurate diagnostic testing. For instance, according to the National Diabetes Statistics Report (2024), an estimated 38.0 million individuals in the U.S. representing 11.6% of the population were living with diabetes, and notably, about 8.7 million adults were unaware of their condition. Globally, the WHO reported in November 2024 that the number of people living with diabetes has exceeded 800 million, highlighting the growing clinical need for continuous monitoring and early detection. A collaborative study conducted by the NCD Risk Factor Collaboration and the WHO found that adult diabetes prevalence has doubl...

  The global urinalysis market size is expected to reach USD 3.07 billion by 2030, expanding at a CAGR of 4.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of UTI worldwide contributes to market growth. According to a study published by SHEA journal, in 2021, approximately 60% to 70% of urinalyses were being performed in patients without symptoms referable to the Gastrointestinal Tract (GU). Increasing geriatric population and the subsequent increase in age related diseases in developed and developing regions will positively influence urinalysis market growth. According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021. The early diagnosis and management of chronic diseases in geriatric population is responsible for the increasing prescription rate for tests such as bilirubin, ketones, glucose, and creatinine. These tests are performed by urinalysis...